Baker McKenzie, with its teams in Singapore, Switzerland, and Japan, served as legal advisor to DBS Bank, UBS, and SBI Digital Asset Holdings in executing the world’s first cross-border repo and natively-issued digital bond
Waterland Private Equity, along with the minority stakeholders of Netrics Holding, has formalized a share purchase agreement for the divestment of all shares in Netrics Group to Bregal Unternehmerkapital, a global private equity firm. Netrics
Luzerner Kantonalbank acted as arranger, agent, security agent and lender, along with other Swiss and Liechtenstein banks as lender in connection with their EUR 150 million financing of GarLa AcquiCo and its subsidiaries, GarLa Group. The
Schellenberg Wittmer, led by partner Olivier Favre (pictured), provided legal support to the Swiss Bankers Association (SBA) for updating its definitions for interest rate products used in over-the-counter derivative transactions documented under the Swiss Master
Homburger provided legal counsel to Commerzbank Aktiengesellschaft for a syndicated corporate financing deal involving Montana Aerospace. This company is a well-known manufacturer of aerospace system components and complex assemblies, operating globally with development and production
Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, has announced the completion of its oversubscribed Series C equity financing raising EUR 67.5m (USD 72m) from a syndicate
LASCCO, a biomedical-technology company, and Abionic, a nanotechnology company, both based at the Biopôle of Lausanne, entered into a licensing agreement with Fapon Biotech, a global leading life sciences company, based in Dongguan (China)
Bär & Karrer announced the opening of a new office in St. Moritz. This expansion highlights the law firm commitment to providing tailored legal and tax advice to private clients and businesses. Acknowledging the
Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) has acquired the 68.0% of the shares in Swiss pharmaceutical company Osmopharm and has disinvested the 76.4% in Egyptian pharmaceutical manufacturer SPIMACO Misr for Pharmaceutical Industries. The Transaction, with
Following its spin-off from Novartis on 4 October 2023, Sandoz, a global leader in the generics and biosimilars markets with one of the broadest port
